Shares of Axovant, Alzheimer’s Drug Developer, Surge on Trading Debut. Pollack, Andrew, Axovant Sciences Ltd., Initial Public Offerings, Biotechnology and Bioengineering, Drugs (Pharmaceuticals), Alzheimer's Disease, GlaxoSmithKline PLC